BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9622445)

  • 21. Effects of acute intra-cerebral administration of the 5-HT(2A/C) receptor ligands DOI and ketanserin on impulse control in rats.
    Hadamitzky M; Koch M
    Behav Brain Res; 2009 Dec; 204(1):88-92. PubMed ID: 19467270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP).
    Callahan PM; Cunningham KA
    Eur J Pharmacol; 1994 May; 257(1-2):27-38. PubMed ID: 8082704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-hydroxytryptamine(2A) receptors regulate sympathetic nerves constricting the cutaneous vascular bed in rabbits and rats.
    Blessing WW; Seaman B
    Neuroscience; 2003; 117(4):939-48. PubMed ID: 12654345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DOI, a 5-HT2A/2C receptor agonist, attenuates clozapine-induced cortical dopamine release.
    Ichikawa J; Dai J; Meltzer HY
    Brain Res; 2001 Jul; 907(1-2):151-5. PubMed ID: 11430898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discriminative stimulus properties of mCPP: evidence for a 5-HT2C receptor mode of action.
    Gommans J; Hijzen TH; Maes RA; Olivier B
    Psychopharmacology (Berl); 1998 Jun; 137(3):292-302. PubMed ID: 9683007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A serotonergic (5-HT2) receptor mechanism in the laterodorsal tegmental nucleus participates in regulating the pattern of rapid-eye-movement sleep occurrence in the rat.
    Amici R; Sanford LD; Kearney K; McInerney B; Ross RJ; Horner RL; Morrison AR
    Brain Res; 2004 Jan; 996(1):9-18. PubMed ID: 14670626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antagonism of 5-hydroxytryptamine(2a) receptors attenuates the behavioral effects of cocaine in rats.
    McMahon LR; Cunningham KA
    J Pharmacol Exp Ther; 2001 Apr; 297(1):357-63. PubMed ID: 11259563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stimulus generalization by fenfluramine in a quipazine-ketanserin drug discrimination is not dependent on indirect serotonin release.
    Smith RL; Gresch PJ; Barrett RJ; Sanders-Bush E
    Pharmacol Biochem Behav; 2002 May; 72(1-2):77-85. PubMed ID: 11900772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for a 5-HT2A receptor mode of action in the anxiolytic-like properties of DOI in mice.
    Nic Dhonnchadha BA; Hascoët M; Jolliet P; Bourin M
    Behav Brain Res; 2003 Dec; 147(1-2):175-84. PubMed ID: 14659583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-HT2A and 5-HT2C/5-HT1B receptors are differentially involved in alcohol preference and consummatory behavior in cAA rats.
    Maurel S; De Vry J; De Beun R; Schreiber R
    Pharmacol Biochem Behav; 1999 Jan; 62(1):89-96. PubMed ID: 9972850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for overshadowing by components of the heterogeneous discriminative stimulus effects of ethanol.
    Green KL; Grant KA
    Drug Alcohol Depend; 1998 Oct; 52(2):149-59. PubMed ID: 9800144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes.
    Song J; Hanniford D; Doucette C; Graham E; Poole MF; Ting A; Sherf B; Harrington J; Brunden K; Stricker-Krongrad A
    Assay Drug Dev Technol; 2005 Dec; 3(6):649-59. PubMed ID: 16438660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the 5-HT2C/2B receptor agonist 1-(3-chlorophenyl) piperazine on plasma glucose levels of rats.
    Sugimoto Y; Yamada J; Yoshikawa T; Horisaka K
    Eur J Pharmacol; 1996 Jun; 307(1):75-80. PubMed ID: 8831107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 5-HT1A receptor agonist flesinoxan shares discriminative stimulus properties with some 5-HT2 receptor antagonists.
    Herremans AH; van der Heyden JA; van Drimmelen M; Olivier B
    Pharmacol Biochem Behav; 1999 Oct; 64(2):389-95. PubMed ID: 10515319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Agonist properties of N,N-dimethyltryptamine at serotonin 5-HT2A and 5-HT2C receptors.
    Smith RL; Canton H; Barrett RJ; Sanders-Bush E
    Pharmacol Biochem Behav; 1998 Nov; 61(3):323-30. PubMed ID: 9768567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of ketanserin on the discrimination of electrical stimulation of the dorsal raphé nucleus in rats.
    Mokler DJ; Abbruzzese S; Trumble V; Whitten B
    Neuropharmacology; 1997; 36(4-5):631-6. PubMed ID: 9225288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Further evidence that the discriminative stimulus properties of indorenate are mediated by 5-HT 1A/1B/2C receptors.
    Miranda F; Hong E; Sánchez H; Velázquez-Martínez DN
    Pharmacol Biochem Behav; 2003 Jan; 74(2):371-80. PubMed ID: 12479957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selectivity of action of typical and atypical anti-psychotic drugs as antagonists of the behavioral effects of 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI).
    Wettstein JG; Host M; Hitchcock JM
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Apr; 23(3):533-44. PubMed ID: 10378235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of tolerance development to 2,5-dimethoxy-4-iodoamphetamine in rats: down-regulation of the 5-HT2A, but not 5-HT2C, receptor.
    Smith RL; Barrett RJ; Sanders-Bush E
    Psychopharmacology (Berl); 1999 Jun; 144(3):248-54. PubMed ID: 10435391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of 5-HT
    Fletcher PJ; Zeeb FD; Browne CJ; Higgins GA; Soko AD
    Psychopharmacology (Berl); 2017 Mar; 234(5):889-902. PubMed ID: 28097374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.